Li Yujie, Huang Dawei, Jia Lianqun, Shangguan Fugen, Gong Shiwei, Lan Linhua, Song Zhiyin, Xu Juan, Yan Chaojun, Chen Tongke, Tan Yin, Liu Yongzhang, Huang Xingxu, Suzuki Carolyn K, Yang Zhongzhou, Yang Guanlin, Lu Bin
The Affiliated Nanhua Hospital and School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
Research (Wash D C). 2023 Jun 16;6:0175. doi: 10.34133/research.0175. eCollection 2023.
Interorganelle contacts and communications are increasingly recognized to play a vital role in cellular function and homeostasis. In particular, the mitochondria-endoplasmic reticulum (ER) membrane contact site (MAM) is known to regulate ion and lipid transfer, as well as signaling and organelle dynamics. However, the regulatory mechanisms of MAM formation and their function are still elusive. Here, we identify mitochondrial Lon protease (LonP1), a highly conserved mitochondrial matrix protease, as a new MAM tethering protein. The removal of LonP1 substantially reduces MAM formation and causes mitochondrial fragmentation. Furthermore, deletion of LonP1 in the cardiomyocytes of mouse heart impairs MAM integrity and mitochondrial fusion and activates the unfolded protein response within the ER (UPR). Consequently, cardiac-specific LonP1 deficiency causes aberrant metabolic reprogramming and pathological heart remodeling. These findings demonstrate that LonP1 is a novel MAM-localized protein orchestrating MAM integrity, mitochondrial dynamics, and UPR, offering exciting new insights into the potential therapeutic strategy for heart failure.
细胞器间的接触和通讯在细胞功能及内环境稳态中发挥着至关重要的作用,这一点已得到越来越多的认可。特别是,线粒体 - 内质网(ER)膜接触位点(MAM)已知可调节离子和脂质转运,以及信号传导和细胞器动态变化。然而,MAM形成的调控机制及其功能仍不清楚。在这里,我们鉴定出线粒体Lon蛋白酶(LonP1),一种高度保守的线粒体基质蛋白酶,作为一种新的MAM锚定蛋白。去除LonP1会显著减少MAM的形成并导致线粒体碎片化。此外,在小鼠心脏的心肌细胞中删除LonP1会损害MAM完整性和线粒体融合,并激活内质网(UPR)内的未折叠蛋白反应。因此,心脏特异性LonP1缺乏会导致异常的代谢重编程和病理性心脏重塑。这些发现表明,LonP1是一种新的定位于MAM的蛋白质,协调MAM完整性、线粒体动态变化和UPR,为心力衰竭的潜在治疗策略提供了令人兴奋的新见解。